OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18

Showing 18 citing articles:

Artificial intelligence in liver cancer — new tools for research and patient management
Julien Caldéraro, Laura Žigutytė, Daniel Truhn, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 8, pp. 585-599
Closed Access | Times Cited: 11

Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer
Ji Shi, Xu Zhu, Jun‐Bo Yang
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Closed Access | Times Cited: 1

Exosome biosensors for detection of liver cancer
Asma Vafadar, Mohammad Younesi, Sepideh Babadi, et al.
Clinica Chimica Acta (2025), pp. 120199-120199
Closed Access

ALDH2 is a novel biomarker and exerts an inhibitory effect on melanoma
Lei Hua, Jinfeng Liao, Xinyu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Sensitive detection of HSP70 using a current-amplified biosensor based on antibody-loaded PS-AuNPs@Cys/Au modified ITO chip
Ruming Liu, Yan Liu, Chaoyu Li, et al.
Microchimica Acta (2024) Vol. 191, Iss. 5
Closed Access | Times Cited: 2

Animal-derived natural products for hepatocellular carcinoma therapy: current evidence and future perspectives
Yichao Liao, Feng Wei, Zhelin He, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Identification of 1-Methylnicotinamide as a specific biomarker for the progression of cirrhosis to hepatocellular carcinoma
Sijia Zhang, Ping Tuo, Yuanye Ji, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 1

Design and synthesis of esterase-activated fluorescent probe for diagnosis and surgical guidance of liver cancer
Yaling Su, Zhongsheng Xu, Jiemin Wang, et al.
Talanta (2024) Vol. 283, pp. 127210-127210
Closed Access | Times Cited: 1

Advances in biomarker identification and validation for oral cancer diagnosis and prognosis
A. S. Vickram, S. Manikandan
Oral Oncology Reports (2024) Vol. 10, pp. 100346-100346
Open Access

Clinical significance of LINC02532 in hepatitis B virus-associated hepatocellular carcinoma and its regulatory effect on tumor progression
Wei Ding, Sujuan Xi, Kewei Gao, et al.
Clinics and Research in Hepatology and Gastroenterology (2024) Vol. 48, Iss. 7, pp. 102403-102403
Closed Access

Pyroptosis and chemical classification of pyroptotic agents
Mohammed A Hara, Mohamed Ramadan, Mohammed K. Abdelhameid, et al.
Molecular Diversity (2024)
Open Access

Construction and validation of a cuproptosis-related genes prognostic model for hepatocellular carcinoma
Xue Wang, Shanshan Ma, Rui Zhu, et al.
Research Square (Research Square) (2023)
Open Access

Development of predictive biomarkers for transarterial chemoembolization efficacy in hepatocellular carcinoma
Dandan Wang, Jinfeng Zhang, Huijie Jiang
Radiology of Infectious Diseases (2023) Vol. 10, Iss. 3, pp. 93-103
Open Access

Page 1

Scroll to top